Search

everythinglearnresearchcommunity

for

Search:↓

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The nanoparticles improved minoxidil's skin absorption, making them promising for skin treatments.

MXD@CP could be a promising new topical treatment for hair loss.

Nexgard successfully treated a husky's demodicosis.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

New cytokine-targeted therapies show promise for treating alopecia areata.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Abrocitinib may effectively treat stubborn alopecia universalis.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Tofacitinib treatment is used for teenagers with alopecia areata.

Cyclosporine effectively treated a woman's stubborn skin condition.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Isoxazole 9 (ISX9) may help regrow hair by activating certain cell signals.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.